The Sonic hedgehog (Shh) signaling pathway plays a critical role in murine gastric development. When Shh is knocked out in the mouse embryonic stomach, glandular epithelial hyperplasia occurs. Furthermore, this phenotype was mimicked in Gli3−/−, but not Gli2−/− stomachs. I utilized three additional mouse models that modulate Gli3 activity to better understand the role of Gli3 in the developing stomach - the Gli3Δ699/Δ699 ,Gli3P1−4/P1−4, and Kif7−/− mice. The Gli3P1−4/P1−4 stomach displayed glandular epithelial overgrowth, as did the Kif7−/− stomach to a lesser extent; the Gli3Δ699/Δ699 stomach displayed glandular hypoplasia. Moreover, the Gli3P1−4/P1−4 and Kif7−/− stomachs have a thicker circular smooth muscle, and the Gli3Δ699/Δ699 had a thinner one relative to wild-type. It appears that altering the balance of Gli3 in favour of its activator results in gastric glandular epithelial and circular smooth muscle hyperplasia, and a balance favouring the Gli3 repressor results in hypoplasia.

The Sonic hedgehog (Shh) signaling pathway plays a critical role in murine gastric development. When Shh is knocked out in the mouse embryonic stomach, glandular epithelial hyperplasia occurs. Furthermore, this phenotype was mimicked in Gli3−/−, but not Gli2−/− stomachs. I utilized three additional mouse models that modulate Gli3 activity to better understand the role of Gli3 in the developing stomach - the Gli3Δ699/Δ699 ,Gli3P1−4/P1−4, and Kif7−/− mice. The Gli3P1−4/P1−4 stomach displayed glandular epithelial overgrowth, as did the Kif7−/− stomach to a lesser extent; the Gli3Δ699/Δ699 stomach displayed glandular hypoplasia. Moreover, the Gli3P1−4/P1−4 and Kif7−/− stomachs have a thicker circular smooth muscle, and the Gli3Δ699/Δ699 had a thinner one relative to wild-type. It appears that altering the balance of Gli3 in favour of its activator results in gastric glandular epithelial and circular smooth muscle hyperplasia, and a balance favouring the Gli3 repressor results in hypoplasia.

Le cancer de la prostate (CaP) est le cancer le plus fréquent chez l'homme et représente la deuxième cause de mortalité par cancer. Cette pathologie est sensible aux androgènes des stades localisés aux stades métastatiques. Après le traitement des formes avancés de ce cIl est admit aujourd'hui que les androgènes seuls ne sont pas suffisants pour déclencher le cancer de la prostate. En effet, le rôle des œstrogènes dans la carcinogenèse prostatique est suggéré par plusieurs études. L'activation de la voie de signalisation Hedgehog (Hh) joue un rôle important dans le développement de plusieurs cancers, y compris le CaP. Une meilleure compréhension des mécanismes qui régulent l'activation de cette voie dans le CaP est nécessaire afin de définir de nouvelles stratégies thérapeutiques plus efficaces.Dans ce travail, nous mettons en évidence l'interaction entre la voie Hh et les hormones stéroïdiennes dans les cellules prostatiques. Nous avons observé : i) une activation de la voie Hh par l'œstrogène (sulfate d'œstrone (SE1)), atténuée par l'anti-œstrogène (ICI) et par l'inhibiteur de la voie Hh (KAAD-cyclopamine), ii) une régulation négative de la voie Hh par l'androgène (dihydrotestostérone (DHT)) et l'œstrogène (17β-œstradiol (E2)). Nous avons démontré que l'inhibition de la voie Hh induite par DHT et E2 est dépendante des récepteurs des androgènes (RA). Cependant, l'effet de SE1 sur la voie Hh pourrait être dépendante des récepteurs des œstrogènes (ER). Enfin, nous avons observé une inhibition de l'activité des RA par KAAD-cyclopamine. Les dérivés de cyclopamine pourraient donc représenter une nouvelle classe d'agents thérapeutiques ciblant le RA dans le cancer de la prostate. Une meilleure caractérisation des cibles potentielles de ces molécules semble être intéressante. / Prostate cancer (PCa) is the most frequent male malignancy and the second most common cause of cancer-related death in men. This cancer is androgen sensitive in its development and progression to metastatic disease. Despite this, increasing evidence suggest that androgens alone are not able to induce PCa and estrogen signaling has a key role in prostate cancer progression. Hedgehog (Hh) pathway activation is important in the growth and development of various carcinomas including PCa. A better understanding of Hh pathway regulating mechanisms in PCa is important in order to identify new therapeutic strategies for this pathology. In this study we investigate the interaction between Hh pathway and steroid hormones in prostate cells. We showed: i) Hh pathway activation by the estrogen (estrone sulfate E1S), attenuated by the anti-estrogen (ICI) and by the Hh pathway inhibitor (KAAD-cyclopamine) ii) Hh pathway negative regulation by the androgen (dihydrotestostérone (DHT)) and the estrogen (17β-estradiol (E2)). Moreover, we showed that Hh pathway inhibition is androgen receptor (AR) dependent. However, E1S effect on this pathway might be estrogen receptor (ER) dependent. Finally, our results suggest that targeting AR signaling by cyclopamine derivatives could be promising therapeutic alternative in prostate cancer, which needs a further investigation.

Alors que le complexe snRNP est bien décrit chez les vertébrés, il nécessite plus d’études chez les invertébrés. Le snARN 7SK sert de maintient structural pour la fixation d’HEXIM à P-TEFb. En retour, HEXIM inhibe l’activité kinase de CDK9 via une fixation directe avec la Cycline T. En conséquence, les interactions entre le snARN 7SK et HEXIM va piéger le complexe P-TEFb sous une forme inactive qui conduit à inhiber l’élongation transcriptionnelle. Dans notre étude, nous montrons qu’un contrôle de l’activité P-TEFb existe aussi chez la Drosophile. Et la dynamique d’équilibre entre les deux formes de P-TEFb dépend également du snARN 7SK. Ce modèle est donc utilisé pour étudier le rôle biologique de la snRNP, et plus spécialement d’HEXIM, dans un contexte intégré. Nous avons donc analysé le profile d’expression d’HEXM durant le cycle de vie de la Drosophile et plus particulièrement pendant l’embryogenèse et l’organogenèse. L’expression permanente et ubiquitaire d’HEXIM suggère qu’elle est nécessaire au développement. Le fait que la perte de fonction d’HEXIM mène à de nombreux et sévères défauts confirme cette hypothèse. En utilisant le modèle des disques imaginaux de l’aile et de l’œil, nous avons étudié plus en profondeur le rôle d’HEXIM et nous avons montré qu’elle est essentielle pour la viabilité cellulaire. De plus, la perte de fonction d’HEXIM conduit à des changements du destin cellulaire et à des modifications des profiles d’expression de plusieurs gènes sélecteurs ou de morphogènes. De façon surprenante, la diminution d’HEXIM induit l’accumulation de Ci155 qui est requise pour activer l’expression de Ptc, ainsi que l’activation ectopique de la voie Hh. Cette accumulation notable de Ci155 est également détectée dans les cellules “immortelles” et dans les tissus en cours de régénération à la suite d’une ablation par voie génétique. Sur la base de ces données, nous proposons un rôle possible de l’accumulation de Ci155 dans le phénomène de prolifération compensatrice. Finalement, nous avons caractérisé un nouvel analogue du snARN 7SK chez la Drosophile, qui a été nommé dm7SK-like snARN. Ce dernier a une structure secondaire très similaire à celle de ces homologues vertébrés, alors que la séquence primaire est assez différente. De plus, presque tous les domaines structuraux importants pour les interactions avec HEXIM et les autres partenaires sont conservés chez cet ARN. Des interactions directes ont été démontrées entre HEXIM et cet ARN suggérant qu’il est un analogue structural du snARN 7SK. Ainsi, la présence de deux analogues du snARN 7SK suggère un autre niveau de régulation de l’expression des gènes, au moins chez la Drosophile. / Whereas 7SK snRNP complex has been well characterized in vertebrates, its activities still remain to be further elucidated in invertebrates. 7SK snRNA serves as a structural scaffold for the efficient binding of HEXIM to P-TEFb. HEXIM in turn inhibits the kinase activity of CDK9 via its direct binding to CyclinT. Consequently, the interaction between 7SK snRNA and HEXIM sequesters the active P-TEFb complex into the inactive form, thereby suppressing the transcription elongation. In this study, we first show that a similar P-TEFb control system exists in Drosophila. In addition, the dynamic equilibrium of the two complexes of P-TEFb in Drosophila also depends on 7SK snRNA. Thank to this similarity, we are able to examine the biological role of 7SK snRNP complex, especially HEXIM protein, in an integrative organism as Drosophila model. We next document the expression profile of HEXIM throughout the life cycle of Drosophila, especially during embryogenesis and organogenesis. The continuous and ubiquitous expression of HEXIM suggests its necessity during development. We demonstrate that HEXIM is indeed essential for the proper development of Drosophila, since its down-regulation results in numerous severe defects. By using wing and eye imaginal discs as study models, we further examine biological roles of HEXIM, and reveal that it is required for cell viability. Moreover, HEXIM knockdown leads to changes in cell fate commitments, and modifications in expression patterns of several selector genes and morphogens. Strikingly, down-regulation of HEXIM significantly induces the accumulation of Ci155, which is required for Ptc expression, and the ectopic activation of Hh signaling. This remarkable accumulation of Ci155 is also detected in “undead cells” and regenerated tissue upon genetic ablation. Given these findings, we thus propose a putative role of Ci155 accumulation in compensatory proliferation. Finally, we characterize a novel analog of 7SK snRNA in Drosophila, which is named dm7SK-like snRNA. This snRNA displays a very similar secondary structure with its vertebrate homologs, although the primary sequence is relatively different. More importantly, almost all of the structural elements crucial for the interaction with HEXIM and other partners are found conserved in this novel dm7SK-like snRNA. A direct interaction between dHEXIM and this snRNA also suggests that it is a functional analog of 7SK snRNA in Drosophila. Thus, the intriguing finding of the two analogs of 7SK snRNA would propose another regulation level of gene expression, at least in Drosophila.

Apoptosis is an intricately regulated cellular process required for the health and homeostasis of living systems. The mitochondrial apoptotic pathway depends on the BCL-2 family of pro- and anti-apoptotic members whose interactions regulate cell fate. BAX and BAK are key pro-apoptotic proteins required for mitochondrial permeabilization during apoptosis. While the mitochondrial death program relies heavily on its protein components, evidences support equally crucial roles for lipids and lipid metabolism in promoting or hindering apoptosis at the mitochondria. To gain insight into the interplay between lipids and BCL-2 proteins we used a liquid chromatography (LC)-mass spectrometry (MS)-based comparative lipidomics approach to uncover lipid changes in the absence of BAX and/or BAK. Our analysis revealed novel functions for BAX and BAK in inflammation and ceramide metabolism. A targeted LC-MS workflow was also developed for characterization of a novel lipid class involved in type 2 diabetes. Targeted LC-MS revealed altered oxysterol metabolism following perturbation of the Sonic hedgehog pathway. Taken together, our findings demonstrate interesting connections among lipids, cell death and disease. / Chemistry and Chemical Biology

Cancers of the human skin are divided into melanoma and non-melanoma. Being among the most commonly diagnosed cancer cases globally, non-melanoma skin cancers are comprised of basal and squamous cell carcinomas. In dermato-pathology, basal cell carcinomas (BCCs) are a frequently encountered diagnosis of skin cancer, and most cases are treated with surgical excisions. While sporadic BCC tumors appear primarily due to aging and ultra-violet exposure, the development of numerous BCCs from a young age is one of the main clinical signs in Gorlin syndrome patients. The critical driver of BCC tumor formation is the sonic hedgehog (SHH) pathway, a pivotal developmental signaling pathway that regulates organ development, cell proliferation, and tissue repair. The majority of all sporadic and syndromic BCCs exhibit mutations in two key components in this pathway, the tumor suppressor gene patched 1 (PTCH1) or the proto-oncogene smoothened (SMO), which result in aberrant pathway activation and continued transcription of SHH-dependent genes. In the last decade, SHH inhibitors have emerged as a novel treatment for advanced and metastatic BCCs. Systemic treatment with vismodegib, a potent SMO inhibitor, can effectively reduce BCC tumor burden in adult Gorlin syndrome patients. However, it is associated with chemotherapy-related adverse events, and treatment cessation results in cancer recurrence and formation of a subset of drug resistant BCCs. While aberrant SHH signaling is key, mechanisms that underlie epithelial–stromal crosstalk and reprograming of tumor metabolism can potentially converge with this pathway and promote BCC tumor development. In this study, we investigated the effects vismodegib on the morphology, behavior, and energy metabolism of human BCC cells and human dermal fibroblasts, in individual cultures as well as in co-cultures, that enabled the crosstalk between these two cell types. Computer-assisted bright-field microscopy was used to characterize cell morphology and behavior. Nuclear magnetic resonance (NMR) and metabolomics were used to determine the metabolic activity of these cells. We found that continuous crosstalk between the cells and different concentrations of vismodegib led to distinct changes in cell morphology and growth, as well as consumption of glucose, pyruvate, and glutamine and secretion of acetate, lactate, and glutamate by these cells. Deciphering tumor driver mechanisms that converge with SHH pathway and contribute to changes within the tumor microenvironment are important not only for better understanding of BCC pathobiology, but also for the development of new mechanism-based BCC therapies with improved clinical outcomes. / 2023-02-22T00:00:00Z

Basal cell carcinoma is the most common form of human malignancy, and as such there are varied methods for treating its various forms. Its more advanced and aggressive forms have required both the use of and advent of therapies which offer differing safety profiles, cost, and efficacy. Two therapies which differ substantially in these respects but have overlap in their recommended use are Mohs micrographic surgery and the pharmaceutical drug vismodegib. Few studies have sought to compare the two methods using these criteria, and as vismodegib has only received FDA approval in the past ten years, it is worthwhile to explore the limitations and advantages of each therapy. In exploring previous clinical trials and retrospective studies, the two therapies are put side by side to contrast their results with their shared intended use. The general findings were that Mohs micrographic surgery remains the gold standard for the treatment of locally advanced basal cell carcinoma, and there are few demonstrable instances in which vismodegib could be deemed a more appropriate therapy. The future of vismodegib appears to be in its use as a neoadjuvant therapy for locally advanced basal cell carcinomas for which a decrease in size by vismodegib would allow for better treatment outcomes.

Clinical management of esophageal adenocarcinoma (EAC) relies on radiation therapy, yet radioresistance is a pervasive challenge in this disease. The mechanisms of EAC radioresistance remain largely unknown due to a paucity of validated preclinical models. The present studies report on the development of seven primary xenograft models established from patient tumours. These models are used to interrogate the range of radiosensitivities and mechanisms of radioresistance in EAC tumours. We found that radiation enriches the tumour-initiating cell population in two xenograft lines tested. Furthermore, three tested xenograft lines respond to irradiation by upregulating Hedgehog transcripts, a pathway involved in stem cell maintenance and proliferation. Upregulation occurs in autocrine and paracrine patterns simultaneously, suggesting that Hedgehog signalling may have a complex role in the radioresponse of EAC tumours. These findings suggest that inhibiting stem cell pathways in combination with radiotherapy may have an important role in the clinical management of EAC.

Die Arbeit beschäftigt sich mit dem Problem der Fettlebererkrankung. In der Einleitung wird auf die aktuelle Relevanz der Gesundheitsstörung und Therapiemöglichkeiten eingegangen, insbesondere durch das, in der Therapie des Diabetes mellitus Typ 2 gebräuchliche Biguanid Metformin. Der Bezug zu molekularbiologischen Signalwegen wird hergestellt und verschiedene in vitro Modellsysteme werden vorgestellt. Anschließend wird auf die Herkunft und genetische Besonderheiten der verwendeten primären Maushepatozyten und Hepatomzellen eingegangen, bevor die angewandten Methoden vorgestellt werden. Zum Einsatz kam in dieser Arbeit vor allem die Lipidmessung mittels Fettrot, um das Ausmaß an Steatosis quantifizierbar zu machen. Im Ergebnisteil folgen zuerst Versuche zur Zytotoxizität der einzelnen Chemikalien und deren Einfluss auf intrazelluläre Energieniveaus, bevor der Einfluss auf die hepatozellulären Fetteinlagerungen im Detail untersucht wird. Unterstützt werden die Ergebnisse durch mikroskopische Bilder der Hepatozyten, welche die beschriebenen Effekte verdeutlichen. Insgesamt konnten folgende Thesen aufgestellt werden: • Zwischen primären Hepatozyten von Wildtyp- und Knockout-Mäusen, bestehen nach 24 stündiger Kultivierung Unterschiede bezüglich des intrazellulären Lipidgehaltes, welche sich nach 72 stündiger Kultivierungszeit nivellieren. • Metformin- und Fructoseinkubation senken den intrazellulären ATP-Gehalt, gleichzeitige Anwesenheit von Metformin und Glucose vermindern den Effekt. • Durch 72-stündige Inkubation der primären Hepatozyten und Behandlung mit Metformin konnte der intrazelluläre Lipidgehalt um circa 40% gesenkt werden. • Durch 72-stündige Inkubation der primären Hepatozyten mit Glucose konnte der intrazelluläre Lipidgehalt um circa 100% gesteigert werden. • Bei humanen Hepatomzellen (HuH7) konnte kein Metformin- und kein Glucoseeffekt beobachtet werden. • Der LXR-Agonist TO901317 wirkt auf den intrazellulären Lipidgehalt Metformin entgegen.

Clinical management of esophageal adenocarcinoma (EAC) relies on radiation therapy, yet radioresistance is a pervasive challenge in this disease. The mechanisms of EAC radioresistance remain largely unknown due to a paucity of validated preclinical models. The present studies report on the development of seven primary xenograft models established from patient tumours. These models are used to interrogate the range of radiosensitivities and mechanisms of radioresistance in EAC tumours. We found that radiation enriches the tumour-initiating cell population in two xenograft lines tested. Furthermore, three tested xenograft lines respond to irradiation by upregulating Hedgehog transcripts, a pathway involved in stem cell maintenance and proliferation. Upregulation occurs in autocrine and paracrine patterns simultaneously, suggesting that Hedgehog signalling may have a complex role in the radioresponse of EAC tumours. These findings suggest that inhibiting stem cell pathways in combination with radiotherapy may have an important role in the clinical management of EAC.